Compare APA & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APA | CRL |
|---|---|---|
| Founded | 1954 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | APA | CRL |
|---|---|---|
| Price | $25.79 | $218.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 19 | 14 |
| Target Price | $25.05 | ★ $193.17 |
| AVG Volume (30 Days) | ★ 5.0M | 632.0K |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.16 | N/A |
| Revenue | ★ $9,376,000,000.00 | $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.68 |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | ★ 4.53 | N/A |
| 52 Week Low | $13.58 | $91.86 |
| 52 Week High | $27.72 | $222.37 |
| Indicator | APA | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 57.15 | 73.12 |
| Support Level | $24.83 | $213.46 |
| Resistance Level | $25.72 | $222.37 |
| Average True Range (ATR) | 0.84 | 5.83 |
| MACD | 0.10 | 0.88 |
| Stochastic Oscillator | 83.69 | 70.10 |
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.